QuickView for choriogonadotropin hormone receptor activity (biogroup)

1. OMIM - Congenital disorder
2. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
3. Drug target sets for approved compounds
4. L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
5. Chemotherapeutic treatment of MCF7, ZR-75-1, HME-CC, and ME16C cell lines

There were no matches for choriogonadotropin hormone receptor activity

1. A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Pha…
2. Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patient…
3. Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles